Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
| $4.6M | ﹤0.01% |
+160,000
| New | +$4.81M |
|
|
COOP
1902
DELISTED
Mr. Cooper
COOP
| $4.6M | ﹤0.01% |
59,014
-45,337
| -43% | -$3.16M |
|
1903
monday.com
MNDY
$3.94B
| $4.6M | ﹤0.01% |
20,363
-189,187
| -90% | -$40.2M |
|
1904
BILL Holdings
BILL
$4.78B
| $4.6M | ﹤0.01% |
66,921
-163,988
| -71% | -$11.5M |
|
1905
ePlus
PLUS
$2.34B
| $4.59M | ﹤0.01% |
58,496
+3,051
| +6% | +$238K |
|
1906
Independent Bank
INDB
$3.97B
| $4.58M | ﹤0.01% |
88,003
-14,144
| -14% | -$782K |
|
1907
PUT
Accenture
ACN
$108B
| $4.58M | ﹤0.01% |
13,200
-130,500
| -91% | -$47.6M |
|
1908
GFL Environmental
GFL
$14.9B
| $4.56M | ﹤0.01% |
132,313
+115,661
| +695% | +$3.99M |
|
1909
Alamos Gold
AGI
$13.9B
| $4.56M | ﹤0.01% |
309,393
-16,168
| -5% | -$204K |
|
|
AXNX
1910
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.56M | ﹤0.01% |
66,135
-51,630
| -44% | -$3.48M |
|
1911
Verra Mobility
VRRM
$744M
| $4.56M | ﹤0.01% |
182,541
-190,210
| -51% | -$4.33M |
|
1912
Twist Bioscience
TWST
$7.25B
| $4.55M | ﹤0.01% |
132,687
-121,299
| -48% | -$4.38M |
|
1913
Beazer Homes USA
BZH
$907M
| $4.55M | ﹤0.01% |
138,625
+71,489
| +106% | +$2.21M |
|
1914
PUT
Coherent
COHR
$74.2B
| $4.55M | ﹤0.01% |
+75,000
| New | +$4.11M |
|
1915
CALL
Corcept Therapeutics
CORT
$12B
| $4.53M | ﹤0.01% |
+180,000
| New | +$4.25M |
|
|
1916
PUT
Corcept Therapeutics
CORT
$12B
| $4.53M | ﹤0.01% |
+180,000
| New | +$4.25M |
|
1917
PUT
RH
RH
$3.71B
| $4.53M | ﹤0.01% |
13,000
-14,500
| -53% | -$3.95M |
|
1918
Iridium Communications
IRDM
$5.29B
| $4.52M | ﹤0.01% |
172,732
+67,562
| +64% | +$2.2M |
|
1919
Global X Uranium ETF
URA
$6.22B
| $4.52M | ﹤0.01% |
156,692
+108,521
| +225% | +$3.14M |
|
1920
DNOW Inc
DNOW
$2.99B
| $4.52M | ﹤0.01% |
297,174
+71,780
| +32% | +$867K |
|
1921
PUT
UnitedHealth
UNH
$370B
| $4.5M | ﹤0.01% |
9,100
-166,400
| -95% | -$84.6M |
|
1922
Matsons
MATX
$6.18B
| $4.49M | ﹤0.01% |
39,952
-32,439
| -45% | -$3.65M |
|
1923
Community Bank
CBU
$3.41B
| $4.49M | ﹤0.01% |
93,415
-34,331
| -27% | -$1.6M |
|
|
GES
1924
PUT
DELISTED
Guess Inc
GES
| $4.48M | ﹤0.01% |
142,400
-76,500
| -35% | -$1.88M |
|
1925
Prestige Consumer Healthcare
PBH
$2.6B
| $4.47M | ﹤0.01% |
61,645
-18,698
| -23% | -$1.25M |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.